Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

Keyword Connections

spectrum
Journals
3
1 spectrochimica acta part a, molecular and biomolecular spectroscopy
2 Chemical communications (Cambridge, England)
3 Plants (Basel, Switzerland)
Research Groups
0
No Research Group Connected
Bibliographies
729
1 Investi̇gati̇on of pyrazoly derivatives schi̇ff base li̇gands and thei̇r metal complexes used as anti-cancer drug.
2 Rhodium(iii)-catalyzed regioselective distal ortho C-H alkenylation of N-benzyl/furanylmethylpyrazoles directed by N-coordinating heterocycles.
3 Frequency, Spectrum, and Stability of Leaf Mutants Induced by Diverse γ-Ray Treatments in Two Hybrids.
4 Gaseous83mKr generator of monoenergetic electrons based on83Rb deposited in zeolite
5 DIRECT NEUTRINO MASS MEASUREMENTS
6 DIRECT NEUTRINO MASS MEASUREMENTS
7 Monte Carlo simulations of low background detectors
8 experimental research of harmonic spectrum of currents at traction drive with pmsm
9 sound spectrum influences auditory distance perception of sound sources located in a room environment
10 the spectrum and some subdivisions of the spectrum of discrete generalized cesàro operators on ℓ p $\ell_{p}$ ( 1 < p < ∞ $1< p<\infty$ )
11 extended method of digital modulation recognition and its testing
12 telecommunications at the crossroads in india
13 on the ideals of extended quasi-nilpotent banach algebras
14 impact of artificially seismic loading on the response of building structure in various site classifications
15 logarithmic sobolev inequality and exponential convergence of a markovian semigroup in the zygmund space
16 basic properties of i-adic algebra
17 Experimental investigation of ligand effects on the conversion electron spectrum of the 22.5 keV M1 + E2 nuclear transition in 149Sm
18 Evolution of nuclear structure with increasing spin and internal excitation energy in 152Dy
19 Evidence for structure in the 1.7 GeV mass region of the K+K− final state centrally produced in the reactions π+p → π+(K+K−)p and pp → p(K+K−)p at 85 GeVc
20 Momentum spectrum and charge excess of cosmic-ray muons at large zenith angles
21 Measurement of Day and Night Neutrino Energy Spectra at SNO and Constraints on Neutrino Mixing Parameters
22 TWIST- The TRIUMF weak interaction symmetry test the Michel parameters from μ+ decay
23 Searches for dark matter annihilation signatures in the Segue 1 satellite galaxy with the MAGIC-I telescope
24 Muon “depth-intensity” relation measured by the LVD underground experiment and cosmic-ray muon spectrum at sea level
25 The effect of electron backscattering on the shape of the63Ni beta -ray spectrum
26 A study of the centrally produced K∗(892)K∗(892)and φω systems in pp interactions at 450 GeV/c
27 Resonances in the chaotic regime. Interpretation in terms of periodic orbits
28 RESULTS FROM THE AMS01 1998 SHUTTLE FLIGHT
29 A DEEPXMM-NEWTONOBSERVATION OF THE QUASAR 3C 287
30 [Paramagnetic spectrum and biological activity of humic series peloid preparations].
31 Differential effects of sympatholytic agents on the power spectrum of rats during the cooling-induced hemodynamic perturbations.
32 Differential effects of sympatholytic agents on the power spectrum of rats during the cooling-induced hemodynamic perturbations.
33 Relaxing Gaze Aversion of Adolescents With Autism Spectrum Disorder in Consecutive Conversations With Human and Android Robot-A Preliminary Study.
34 First behavioural assessment of a novel Immp2l knockdown mouse model with relevance for Gilles de la Tourette syndrome and Autism spectrum disorder.
35 Antifungal spectrum characterization and identification of strong volatile organic compounds produced by TM-R.
36 Spectrum adapted the expectation-maximization algorithm for high-throughput peak shift analysis.
37 Biologically active metabolite(s) from haemolymph of red-headed centipede Scolopendra subspinipes possess broad spectrum antibacterial activity
38 [Outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit: Risk factors and key preventive measures for eradication in record time].
39 Potential for repurposing the personal care product preservatives bronopol and bronidox as broad-spectrum antibiofilm agents for topical application.
40 Multilocus sequence typing and blaESBL characterization of extended-spectrum beta-lactamase-producing Escherichia coli isolated from healthy humans and swine in Northern Thailand
41 Psychoactive drug prescription and urine colonization with extended-spectrum &beta;-lactamase-producing Enterobacteriaceae
42 Phenotypic and genotypic characterization of multi-drug-resistant Escherichia coli isolates harboring blaCTX-M&nbsp;group&nbsp;extended-spectrum &beta;-lactamases recovered from pediatric patients in Shenzhen, southern China
43 Cefuroxime compared to piperacillin/tazobactam as empirical treatment of Escherichia coli bacteremia in a low Extended-spectrum beta-lactamase (ESBL) prevalence cohort
44 Simulating moxalactam dosage for extended-spectrum &beta;-lactamase-producing Enterobacteriaceae using blood antimicrobial surveillance network data
45 Prevalence and risk factors for colonization by extended-spectrum &beta;-lactamase-producing or ST 131 Escherichia coli among asymptomatic adults in community settings in Southern Taiwan
46 High rates of CTX-M group-1 extended-spectrum &beta;-lactamases producing Escherichia coli from pets and their owners in Faisalabad, Pakistan
47 Emergence and molecular characterization of multidrug-resistant Klebsiella pneumoniae isolates harboring blaCTX-M-15 extended-spectrum &beta;-lactamases causing ventilator-associated pneumonia in China
48 Phenotypic and genotypic characterizations of extended-spectrum beta-lactamase-producing Escherichia coli in Thailand
49 Microbial spectrum and drug-resistance profile of isolates causing bloodstream infections in febrile cancer patients at a referral hospital in Addis Ababa, Ethiopia
50 Epidemiology of and risk factors for infection with extended-spectrum &beta;-lactamase-producing carbapenem-resistant Enterobacteriaceae: results of a double case&ndash;control study
51 Antibiotic resistance pattern and molecular characterization of extended-spectrum &beta;-lactamase producing enteroaggregative Escherichia coli isolates in children from southwest Iran
52 Epidemiology and molecular characterization of multidrug-resistant Escherichia coli isolates harboring blaCTX-M group 1 extended-spectrum &beta;-lactamases causing bacteremia and urinary tract infection in Manhi&ccedil;a, Mozambique
53 Moxalactam is not more active on extended spectrum&nbsp;&beta;-lactamase (ESBL) producing bacteria than on non-ESBL producers
54 Carriage of colistin-resistant, extended-spectrum &beta;-lactamase-producing Escherichia coli harboring the mcr-1 resistance gene after short-term international travel to Vietnam
55 Antibacterial effect evaluation of moxalactam against extended-spectrum &beta;-lactamase-producing Escherichia coli and Klebsiella pneumoniae with in vitro pharmacokinetics/pharmacodynamics simulation
56 Once-daily intramuscular amikacin for outpatient treatment of lower urinary tract infections caused by extended-spectrum &beta;-lactamase-producing Escherichia coli in children
57 Microbiome disruption and recovery in the fish Gambusia affinis following exposure to broad-spectrum antibiotic
58 Extended-spectrum beta-lactamase- and carbapenemase-producing Enterobacteriaceae among Ethiopian children
59 Occurrence of extended-spectrum and AmpC &beta;-lactamases in multiple drug resistant Salmonella isolates from clinical samples in Lagos, Nigeria
60 blaCTX-M-I group extended spectrum beta lactamase-producing Salmonella typhi from hospitalized patients in Lagos, Nigeria
61 Wide dissemination of extended-spectrum &beta;-lactamase-producing Escherichia coli in community residents in the Indochinese peninsula
62 Mortality and molecular epidemiology associated with extended-spectrum &beta;-lactamase production in Escherichia coli from bloodstream infection
63 Risk factors for infections with extended- spectrum beta-lactamase-producing Escherichia coli in a county of Southern Sweden
64 Prevalence of extended-spectrum beta-lactamase-producing bacteria in food
65 High prevalence of extended-spectrum &beta;-lactamase-producing pathogens: results of a surveillance study in two hospitals in Ujjain, India
66 Psychocardiology: the spectrum of stress in the genesis of heart disease: a point of view
67 Multilocus sequence typing and blaESBL characterization of extended-spectrum beta-lactamase-producing Escherichia coli isolated from healthy humans and swine in Northern Thailand
68 Psychoactive drug prescription and urine colonization with extended-spectrum &beta;-lactamase-producing Enterobacteriaceae
69 Multilocus sequence typing and blaESBL characterization of extended-spectrum beta-lactamase-producing Escherichia coli isolated from healthy humans and swine in Northern Thailand
70 Psychoactive drug prescription and urine colonization with extended-spectrum &beta;-lactamase-producing Enterobacteriaceae
71 Parry–Romberg Syndrome with Uhthoff’s Phenomena: A Spectrum of Autoimmune Disease?
72 Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Meningitis and Cerebral Abscess in a Neonate: Therapeutic Challenge
73 The Big Yawning: Pathological Yawning as a Symptom of Neuromyelitis Optica Spectrum Disorders
74 Phenotypic and genotypic characterization of multi-drug-resistant Escherichia coli isolates harboring blaCTX-M&nbsp;group&nbsp;extended-spectrum &beta;-lactamases recovered from pediatric patients in Shenzhen, southern China
75 Cefuroxime compared to piperacillin/tazobactam as empirical treatment of Escherichia coli bacteremia in a low Extended-spectrum beta-lactamase (ESBL) prevalence cohort
76 Simulating moxalactam dosage for extended-spectrum &beta;-lactamase-producing Enterobacteriaceae using blood antimicrobial surveillance network data
77 Prevalence and risk factors for colonization by extended-spectrum &beta;-lactamase-producing or ST 131 Escherichia coli among asymptomatic adults in community settings in Southern Taiwan
78 High rates of CTX-M group-1 extended-spectrum &beta;-lactamases producing Escherichia coli from pets and their owners in Faisalabad, Pakistan
79 Emergence and molecular characterization of multidrug-resistant Klebsiella pneumoniae isolates harboring blaCTX-M-15 extended-spectrum &beta;-lactamases causing ventilator-associated pneumonia in China
80 Phenotypic and genotypic characterizations of extended-spectrum beta-lactamase-producing Escherichia coli in Thailand
81 Microbial spectrum and drug-resistance profile of isolates causing bloodstream infections in febrile cancer patients at a referral hospital in Addis Ababa, Ethiopia
82 Epidemiology of and risk factors for infection with extended-spectrum &beta;-lactamase-producing carbapenem-resistant Enterobacteriaceae: results of a double case&ndash;control study
83 Antibiotic resistance pattern and molecular characterization of extended-spectrum &beta;-lactamase producing enteroaggregative Escherichia coli isolates in children from southwest Iran
84 Epidemiology and molecular characterization of multidrug-resistant Escherichia coli isolates harboring blaCTX-M group 1 extended-spectrum &beta;-lactamases causing bacteremia and urinary tract infection in Manhi&ccedil;a, Mozambique
85 Moxalactam is not more active on extended spectrum&nbsp;&beta;-lactamase (ESBL) producing bacteria than on non-ESBL producers
86 Carriage of colistin-resistant, extended-spectrum &beta;-lactamase-producing Escherichia coli harboring the mcr-1 resistance gene after short-term international travel to Vietnam
87 Antibacterial effect evaluation of moxalactam against extended-spectrum &beta;-lactamase-producing Escherichia coli and Klebsiella pneumoniae with in vitro pharmacokinetics/pharmacodynamics simulation
88 Once-daily intramuscular amikacin for outpatient treatment of lower urinary tract infections caused by extended-spectrum &beta;-lactamase-producing Escherichia coli in children
89 Microbiome disruption and recovery in the fish Gambusia affinis following exposure to broad-spectrum antibiotic
90 Extended-spectrum beta-lactamase- and carbapenemase-producing Enterobacteriaceae among Ethiopian children
91 Occurrence of extended-spectrum and AmpC &beta;-lactamases in multiple drug resistant Salmonella isolates from clinical samples in Lagos, Nigeria
92 blaCTX-M-I group extended spectrum beta lactamase-producing Salmonella typhi from hospitalized patients in Lagos, Nigeria
93 Wide dissemination of extended-spectrum &beta;-lactamase-producing Escherichia coli in community residents in the Indochinese peninsula
94 Mortality and molecular epidemiology associated with extended-spectrum &beta;-lactamase production in Escherichia coli from bloodstream infection
95 Risk factors for infections with extended- spectrum beta-lactamase-producing Escherichia coli in a county of Southern Sweden
96 Prevalence of extended-spectrum beta-lactamase-producing bacteria in food
97 High prevalence of extended-spectrum &beta;-lactamase-producing pathogens: results of a surveillance study in two hospitals in Ujjain, India
98 Super-Resolution of Magnetic Resonance Images via Convex Optimization with Local and Global Prior Regularization and Spectrum Fitting
99 ALTRIRAS: A Computer Game for Training Children with Autism Spectrum Disorder in the Recognition of Basic Emotions
100 Psychocardiology: the spectrum of stress in the genesis of heart disease: a point of view
101 A Broader Look: Camera-Based Vital Sign Estimation across the Spectrum.